The Association Between Obstructive Sleep Apnea Defined by 3 Percent Oxygen Desaturation or Arousal Definition and Self-Reported Cardiovascular Disease in the Sleep Heart Health Study
- PMID: 33163289
- PMCID: PMC7644074
- DOI: 10.13175/swjpcc054-20
The Association Between Obstructive Sleep Apnea Defined by 3 Percent Oxygen Desaturation or Arousal Definition and Self-Reported Cardiovascular Disease in the Sleep Heart Health Study
Abstract
Background: Studies have established that OSA defined using a hypopnea definition requiring a ≥4% oxygen desaturation (AHI4%) is associated with cardiovascular (CVD) or coronary heart (CHD) disease. This study determined whether OSA defined using a hypopnea definition characterized by a ≥3% oxygen desaturation or an arousal (AHI3%A) is associated with CVD/CHD.
Methods: Data were analyzed from 6307 Sleep Heart Health Study participants who had polysomnography. Self-reported CVD included angina, heart attack, heart failure, stroke, previous coronary bypass surgery or angioplasty. Self-reported CHD included the aforementioned conditions but not stroke or heart failure. The association between OSA and CVD/CHD was examined using logistic regression models with stepwise inclusion of demographic, anthropometric, social/behavioral and co-morbid medical conditions. A parsimonious model in which diabetes and hypertension were excluded because of their potential to be on the causal pathway between OSA and CVD/CHD also was constructed.
Results: For CVD, the odds ratios and 95% confidence intervals for AHI3%A ≥30/hour were 1.39 (1.03-1.87) and 1.45 (1.09-1.94) in the fully adjusted and parsimonious models. Results for CHD were 1.29 (0.96-1.74) and 1.36 (0.99-1.85). In participants without OSA according to more stringent AHI4% criteria but with OSA using the AHI3%A definition, similar findings were observed.
Conclusion: OSA defined using an AHI3%A is associated with both CVD and CHD. Use of a more restrictive AHI4% definition will misidentify a large number of individuals with OSA who have CVD or CHD. These individuals may be denied access to therapy, potentially worsening their underlying CVD or CHD.
Figures
References
-
- Mashaqi S, Gozal D. The impact of obstructive sleep apnea and PAP therapy on all-cause and cardiovascular mortality based on age and gender - a literature review. Respir Investig 2020;58(1):7–20. S2212–5345(19)30159–5 [pii] - PubMed
-
- Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597–619. 10.5664/jcsm.2172 [doi] - DOI - PMC - PubMed
-
- Anonymous. CPAP for Obstructive Sleep Apnea. Last Updated: 2020. Accessed: 09/14, 2020 https://www.cms.gov/Medicare/Coverage/Coverage-with-Evidence-Development....
Grants and funding
- U01 HL053916/HL/NHLBI NIH HHS/United States
- R25 HL126140/HL/NHLBI NIH HHS/United States
- U01 HL063463/HL/NHLBI NIH HHS/United States
- R21 CA184920/CA/NCI NIH HHS/United States
- R01 MD011600/MD/NIMHD NIH HHS/United States
- U01 HL053941/HL/NHLBI NIH HHS/United States
- U01 HL128954/HL/NHLBI NIH HHS/United States
- U01 HL053937/HL/NHLBI NIH HHS/United States
- R33 HL151254/HL/NHLBI NIH HHS/United States
- R01 HL095799/HL/NHLBI NIH HHS/United States
- R21 AG059202/AG/NIA NIH HHS/United States
- U01 HL053931/HL/NHLBI NIH HHS/United States
- UG3 HL140144/HL/NHLBI NIH HHS/United States
- U01 HL053938/HL/NHLBI NIH HHS/United States
- R61 HL151254/HL/NHLBI NIH HHS/United States
- U01 HL064360/HL/NHLBI NIH HHS/United States
- U01 HL053934/HL/NHLBI NIH HHS/United States
- U01 HL063429/HL/NHLBI NIH HHS/United States
- R56 HL138377/HL/NHLBI NIH HHS/United States
- R01 AI135108/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources